Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

Atrial fibrillation (AFib) affects an estimated three million to six million Americans—and a 2020 Journal of the American ...

It beats around 60-100 times per minute when you're resting. If you have atrial fibrillation, though, your heart can beat out of rhythm, too fast, or too slow. Untreated AFib might also make you ...

If you have AFib, treating it cuts your risk of having a stroke. But it can be costly, even if you have insurance. AFib doesn’t so much have types as it has durations. Doctors classify it by how ...

Atrial fibrillation (AFib) is an irregular and often rapid heart rhythm. The terms “controlled AFib” and “uncontrolled AFib” describe whether treatment strategies are effectively managing ...

It was safe to start direct oral anticoagulant (DOAC) therapy without delay after acute ischemic stroke in people with atrial ...

Atrial fibrillation, or AFib is the most common type of heart arrhythmia. It’s estimated 12 million people in the U.S. are living with it. If not treated, it can lead to blood clots and stroke.

Individuals who intend to improve their cardiovascular health often use Magnesium supplements, particularly those dealing with atrial fibrillation (afib). Afib is a condition marked by an ...

Q: I’m 63 and have been diagnosed with atrial fibrillation. I wonder what you know about medical care and self-care for the condition. Thanks. -- Donna M., Lafayette, Indiana A: You’re part of ...

After multiple medical procedures starting in May 2022, Arthur Schiebel was pleased to have his atrial fibrillation under control. He was less pleased to find out he’d need to take blood ...

Thus, it is a serious condition that must be monitored. Atrial flutter is similar to atrial fibrillation, more commonly known as "AFib," but there is a key difference. According to Johns Hopkins ...

“As a result of this accelerated conversion, we now expect PFA to likely exceed our previously communicated range of 40% to 60% of global afib ablations by 2026.” Boston Scientific also ...